A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults

Clinical trial NCT07226882 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07226882
Sponsor: Pfizer
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Lyme Borreliosis

Start date: 2025-11-19
Primary completion: 2028-01-27
Enrollment: 207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.